한글목차

만성 골반통 치료 시장 규모는 2025년 73억 6,000만 달러에서 2026-2034년에 CAGR 4.22%로 성장하며, 2034년에는 106억 7,000만 달러에 달할 것으로 예측되고 있습니다.

만성골반통 치료 시장은 만성골반통(CPP)과 삶의 질에 미치는 영향에 대한 인식이 높아짐에 따라 괄목할 만한 성장세를 보이고 있습니다. 만성골반통은 자궁내막증, 골반내 염증성 질환, 간질성 방광염 등 다양한 기저질환에 기인할 수 있으며, 효과적인 치료방법의 선택이 요구되고 있습니다. 이러한 질환의 유병률 증가와 여성 건강에 대한 관심 증가는 만성 골반통 치료 솔루션에 대한 투자를 촉진하고 시장을 더욱 확대할 수 있는 동력이 되고 있습니다.

기술 발전은 만성 골반통 치료 시장 전망를 형성하는 데 중요한 역할을 하고 있습니다. 최소침습적 수술 기술, 약물 치료, 물리치료의 혁신은 만성 골반통의 관리를 개선하고 있습니다. 또한 원격의료와 디지털 헬스 솔루션의 통합으로 의료 서비스 접근성이 향상되고 환자 맞춤형 치료 계획을 수립할 수 있게 되었습니다. 제조업체와 의료 서비스 프로바이더들이 혁신을 거듭하고 새로운 솔루션을 개발함에 따라 만성 골반통 치료 시장은 다양한 의료 현장에서 채택이 확대될 것으로 예측됩니다.

또한 만성 골반통 관리에서 다직종 협력 접근에 대한 중요성이 높아지는 것도 시장의 성장 궤도에 영향을 미치고 있습니다. 의료진이 만성 골반통의 복잡성을 인식함에 따라 신체적, 심리적 측면을 모두 다루는 종합적인 치료 계획에 대한 수요가 증가하고 있습니다. 이러한 추세는 부인과 전문의, 통증 관리 전문가, 정신건강 전문가 등 전문 의료진 간의 협업을 촉진하여 환자의 치료 결과를 향상시키는 통합적 치료 경로의 개발을 촉진하고 있습니다. 시장이 계속 진화하는 가운데, 기술 도입, 다직종 협력 진료, 환자 중심 접근 방식의 통합은 성공의 중요한 원동력이 될 것입니다.

목차

제1장 서론

제2장 개요

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 만성 골반통 치료 시장 : 기술별

제5장 세계의 만성 골반통 치료 시장 : 유통 채널별

제6장 세계의 만성 골반통 치료 시장 : 지역별

제7장 경쟁 구도

제8장 기업 개요

영문목차

The Chronic Pelvic Pain Treatment Market size is expected to reach USD 10.67 Billion in 2034 from USD 7.36 Billion (2025) growing at a CAGR of 4.22% during 2026-2034.

The Chronic Pelvic Pain Treatment Market is experiencing significant growth as the awareness of chronic pelvic pain (CPP) and its impact on quality of life increases. Chronic pelvic pain can result from various underlying conditions, including endometriosis, pelvic inflammatory disease, and interstitial cystitis, necessitating effective treatment options. The rising prevalence of these conditions and the growing focus on women's health are driving investments in chronic pelvic pain treatment solutions, further propelling market expansion.

Technological advancements are playing a crucial role in shaping the future of the chronic pelvic pain treatment market. Innovations in minimally invasive surgical techniques, pharmacological therapies, and physical therapy modalities are enhancing the management of chronic pelvic pain. Additionally, the integration of telemedicine and digital health solutions is improving access to care and enabling personalized treatment plans for patients. As manufacturers and healthcare providers continue to innovate and develop new solutions, the chronic pelvic pain treatment market is likely to see increased adoption across various healthcare settings.

Moreover, the growing emphasis on multidisciplinary approaches to chronic pelvic pain management is influencing the market's growth trajectory. As healthcare providers recognize the complexity of CPP, there is a rising demand for comprehensive treatment plans that address both physical and psychological aspects of the condition. This trend is driving collaboration between specialists, including gynecologists, pain management experts, and mental health professionals, to develop integrated care pathways that improve patient outcomes. As the market continues to evolve, the integration of technology, multidisciplinary care, and patient-centered approaches will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Medications (Pain Relievers, Hormone Treatments, Antibiotics, Antidepressants)
• Surgery (Laparoscopic Surgery, Hysterectomy)
• Others

By Distribution Channel

• Retail Pharmacies & Drug stores
• E-commerce
• Others

COMPANIES PROFILED

• BayerAG, Becton, Dickinson and Company, GlaxoSmithKline pic, Hospiinz, Intuitive Surgical, MAST PAK SURGICAL CORP, Mayne Pharma Group Limited, Medtronic, Perigo Company pic

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CHRONIC PELVIC PAIN TREATMENT MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Medications (Pain Relievers, Hormone Treatments, Antibiotics, Antidepressants) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Surgery (Laparoscopic Surgery, Hysterectomy) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CHRONIC PELVIC PAIN TREATMENT MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Retail Pharmacies & Drug stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. E-commerce Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CHRONIC PELVIC PAIN TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Technology
  • 6.2.2 By Distribution Channel
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Technology
  • 6.3.2 By Distribution Channel
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Technology
  • 6.4.2 By Distribution Channel
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Technology
  • 6.5.2 By Distribution Channel
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Technology
  • 6.6.2 By Distribution Channel
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CHRONIC PELVIC PAIN TREATMENT INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 BayerAG
  • 8.2.2 Becton
  • 8.2.3 Dickinson And Company
  • 8.2.4 GlaxoSmithKline Pic
  • 8.2.5 Hospiinz
  • 8.2.6 Intuitive Surgical
  • 8.2.7 MAST PAK SURGICAL CORP
  • 8.2.8 Mayne Pharma Group Limited
  • 8.2.9 Medtronic
  • 8.2.10 Perigo Company Pic